NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Maybe, maybe not. Perhaps it's up to the company how exactly they want to phrase it. I'd much prefer reading "Acceptance" than a second "Validation.

>>EQRx – a focused on expanding access to innovative medicines – has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has accepted a marketing authorisation application (MAA) for sugemalimab.

>>Melanie Nallicheri, president and chief executive officer at EQRx, reflected: “With the acceptance of this application, we now have two investigational therapies under review with the MHRA in non-small cell lung cancer,